0001943773-22-000002.txt : 20220912 0001943773-22-000002.hdr.sgml : 20220912 20220912151320 ACCESSION NUMBER: 0001943773-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220912 DATE AS OF CHANGE: 20220912 EFFECTIVENESS DATE: 20220912 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 4J Therapeutics Inc. CENTRAL INDEX KEY: 0001943773 IRS NUMBER: 883625495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-458589 FILM NUMBER: 221238491 BUSINESS ADDRESS: STREET 1: 965 CLARK WAY CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 650-575-4107 MAIL ADDRESS: STREET 1: 965 CLARK WAY CITY: PALO ALTO STATE: CA ZIP: 94304 D 1 primary_doc.xml X0708 D LIVE 0001943773 4J Therapeutics Inc. 965 CLARK WAY PALO ALTO CA CALIFORNIA 94304 650-575-4107 DELAWARE None None Corporation true 2022 Menashe Elazar 965 Clark Way Palo Alto CA CALIFORNIA 94304 Executive Officer Director Nancy Chang 101 Westcott St Unit 603 Houston TX TEXAS 77007 Executive Officer Edward Pham 3358 Bryant Street Palo Alto CA CALIFORNIA 94306 Executive Officer Director Jeffrey S. Glenn 2061 Webster Street Palo Alto CA CALIFORNIA 94301 Director Pharmaceuticals Decline to Disclose 06b false 2022-08-09 false true false 0 10000 10000 0 true 1 4 0 0 0 false 4J Therapeutics Inc. /s/ Menashe Elazar Menashe Elazar Treasurer 2022-09-12